HAMPTON, N.J. , Nov. 07, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics , Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 7,425,000 shares of its common stock at a public offering price of $27.00 per share.